In addition, studies also showed that the low expression of FOXD3 could accelerate the evolution of breast cancer by promoting EMT [13], while its overexpression could significantly inhibit the growth of lung cancer [24], liver cancer [25], and melanoma cells [26]; these results were also consistent with the current study results. Here, FOXD3 is linked to liver cancer.